Philadelphia associate Debora Plehn-Dujowich will moderate an upcoming webinar for the American Intellectual Property Law Association (AIPLA) Biotech Committee on Tuesday, March 26.

Funding is tight and risk is high in the development of new drugs and diagnostics.  Creative financing and partnering structures are allowing companies to access funding to run clinical trials and generate new IP.  The objective of this webinar is to describe the novel arrangements and IP issues that patent professionals need to know.

For more information, click here.



Source: AIPLA Biotech Committee